Xilio Development Inc (US: XLO) — Healthcare · Share Price, Chart & Market Data
About: Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $8.31 (-1.89%)
XLOXilio Development Inc
Loading watchlist status…
Trade XLO now
Xilio Development Inc share price
XLO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
25 Apr, 4:44 pm GMT+0
XLO price performance
-1.657%
5D
-0.717%
1M
-11.671%
YTD
-29.168%
1Y
XLO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
25 Apr, 4:44 pm GMT+0
XLO details
XLO Market Signals